Target intelligence / Profile preview

3-Methylcrotonyl-CoA carboxylase (MCC)

Target
MCC
Molecular classification
Enzyme, Biotin-dependent carboxylase, Acyl-CoA carboxylase family, Mitochondrial protein
01

Overview

3-Methylcrotonyl-CoA carboxylase (MCC) is a mitochondrial, biotin-dependent enzyme composed of two subunits (alpha and beta, encoded by MCCC1 and MCCC2 respectively) that catalyzes the carboxylation of 3-methylcrotonyl-CoA to 3-methylglutaconyl-CoA, a key step in the catabolic pathway of the essential amino acid leucine[1][3][4][5][7]. This reaction ultimately supports energy production by contributing to acetyl-CoA and acetoacetate pools. MCC deficiency is a well-characterized inborn error of metabolism leading to methylcrotonylglycinuria, and its diagnosis relies on detection of characteristic metabolites or reduced enzyme activity; the condition is often treatable with biotin supplementation due to the enzyme's strict requirement for biotin as a cofactor[4][6]. MCC belongs to the acyl-CoA carboxylase family, shares structural homology with propionyl-CoA carboxylase, and is widely conserved across mammals, plants, and bacteria[1][3][5][6][7].

Other names
3-methylcrotonoyl-CoA carboxylaseMethylcrotonyl-CoA carboxylaseMethylcrotonoyl-CoA carboxylaseMCC
02

Mechanism of action

Biotin supplementation: provides essential cofactor to restore or improve MCC activity in deficiency states No specific small-molecule inhibitors/activators of MCC in clinical use

03

Biological functions

Catabolism of amino acid leucineCarboxylation of 3-methylcrotonyl-CoA to 3-methylglutaconyl-CoAFatty acid and amino acid metabolismEnergy production via acetyl-CoA and acetoacetate formation
04

Disease associations

Inborn error of metabolism (methylcrotonylglycinuria, also called 3-methylcrotonyl-CoA carboxylase deficiency)Metabolic acidosisHypoglycemiaCarnitine deficiency
05

Safety considerations

MCC deficiency can be severe, particularly during metabolic stress: symptoms include vomiting, metabolic acidosis, hypoglycemia, and potential neurologic damage if untreatedBiotin supplementation is generally safe, but prompt therapy is critical for symptomatic individuals
06

Interacting drugs

Biotin (vitamin B7) is a cofactor essential for enzyme function; therapeutic supplementation with biotin can be beneficial in MCC deficiency
07

Biomarkers

3-methylcrotonylglycine (urine)3-hydroxyisovaleric acid (urine)Decreased MCC activity in cultured fibroblasts or lymphocytesElevated leucine and metabolites in plasma and urine

Beyond the preview

Go deeper on 3-Methylcrotonyl-CoA carboxylase (MCC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-Methylcrotonyl-CoA carboxylase (MCC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call